AiCure

Covance

PRA Health Sciences becomes latest big CRO to launch IPO

Thursday, November 13, 2014 03:38 PM

PRA Health Sciences launched its initial public offering this morning, raising $306 million from the sale of nearly 17 million shares at $18 per share—below plans it announced in September to raise up to $375 million.

More... »


LabCorp to acquire Covance, creating giant one-stop shop for diagnostics, clinical research

Monday, November 3, 2014 12:57 PM

Laboratory Corp. of America Holdings (LabCorp), a large provider of medical testing services, has agreed to acquire CRO Covance in a $6.1 billion cash and stock deal to create a giant healthcare diagnostics company.      

More... »


Covance, Novartis collaborate to develop a clinical data warehouse

Wednesday, October 15, 2014 01:21 PM

Covance has entered an in-kind collaboration with Novartis Institutes for Biomedical Research (NIBR) to accelerate the development of a state-of-the-art clinical data warehouse designed to support data integration and meta-analysis for preclinical and clinical research.

More... »

New ACRO survey: CRO members saw big growth in past decade

Friday, September 19, 2014 03:34 PM

The biopharmaceutical industry’s outsourcing strategy has enabled the eight members of the Association of Clinical Research Organizations (ACRO) to double in size over the past 10 years, today employing more than 100,000 professionals worldwide with a global payroll of nearly $6 billion.

More... »

Covance, Frenova Renal Research collaborate

Wednesday, September 17, 2014 02:23 PM

Covance, a Princeton, N.J.-based global drug development services company, and Frenova Renal Research, a Fresenius Medical Care North America (FMCNA) company based in Waltham, Mass., have announced a new research collaboration designed to find more effective treatments for patients living with chronic kidney disease (CKD) and end stage renal disease (ESRD).

More... »

Aptuit names Paul Overton EVP, business development & marketing

Tuesday, July 22, 2014 08:00 AM

Aptuit, a provider of integrated early to mid-phase drug development services, has appointed Paul D. Overton, Ph.D., executive vice president, business development and marketing, making him responsible for all of Aptuit's sales and marketing activities.

More... »

Covance adds two to clinical development services leadership team

Monday, July 14, 2014 01:04 PM

Covance has announced two key additions to its clinical development services scientific leadership team with the appointments of Robert Wasserman, M.D., as vice president and global therapeutic area head, oncology, and Rogelio Mosqueda-Garcia, M.D., Ph.D., as global vice president, early clinical services within medical and scientific affairs. Both are based in Princeton, N.J.

More... »

Covance launches MarketPlace for biopharmaceutical development

Monday, June 23, 2014 01:36 PM

CRO Covance has introduced Covance MarketPlace, a new solution that enables Covance’s emerging biotechnology and established pharmaceutical clients to easily find and forge new partnerships in a secure forum.

More... »

Discovery Labs adds to scientific leadership team

Friday, May 23, 2014 12:23 PM

Discovery Laboratories, a specialty biotechnology company dedicated to advancing a new standard in respiratory critical care, has strengthened its scientific leadership. Effective immediately, Steve Simonson, M.D., M.H.S., has joined the company as vice president, Clinical Development, and Lawrence Weinstein has joined as vice president, Medical Device Development.

More... »

Covance acquires Medaxial

Monday, May 19, 2014 01:29 PM

CRO Covance has acquired Medaxial, a London-based value communication consultancy. The company specializes in an integrated approach to market access strategy, health economic modeling and data dissemination services, and focuses on defining and communicating the value of a biopharmaceutical product or medical device to healthcare payers and the stakeholders who influence them.

More... »

CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

November 24

Tufts CSDD’s $2.6 billion price tag to develop and bring a new drug to market raises questions, criticisms

Medidata joins GlaxoSmithKline in study to evaluate the impact of wearing mobile devices in clinical trials

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

November

Private equity driving dynamic CRO growth
Enables CROs to pursue long-term strategies, while giving the space credibility

Baby boomers poised to reshape clinical trials industry
Millions of tech-savvy consumers already track their health, expect new treatments as they age

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

October

CROs driving changes in patient recruitment
Data- and tech-aided enrollment services a competitive advantage

Trials with in-home nurses poised to grow
Higher expense, but may improve recruitment and retention for select trials

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs